LCZ696

LCZ696 is an investigational drug used to treat heart failure.

LCZ696 Overview

Reviewed: February 10, 2015
Updated: 

LCZ696 is is an investigational drug used to treat heart failure.

LCZ696 is a single product containing 2 medications: sacubitril and valsartan.

LCZ696 belongs to a group of drugs called angiotensin receptor neprilysin inhibitor. It is thought to reduce the strain on the failing heart

Sacubitril works by blocking neprilysin, an enzyme that contributes to the breakdown of certain heart compounds that affect heart function.

Valsartan works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently.

LCZ696 is being studied by Novartis.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

LCZ696 Cautionary Labels

Back to Top
precautionsprecautions

Manufacturer

Back to Top

LCZ696 Drug Class

Back to Top

LCZ696 is part of the drug class: